ArticleInternational journal of retina and vitreous2025
Retinal microvasculature and macular-choroidal thickness in oral contraceptive users: an OCTA and OCT comparative study.
Article in International journal of retina and vitreous, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPotential retinal vascular changes associated with hormonal contraceptive use remain insufficiently characterized in the literature. Optical coherence tomography angiography (OCTA) enables a noninvasive and highly detailed evaluation of retinal microvasculature. This study aimed to assess the superficial and deep retinal capillary plexuses, and macular and choroidal thickness in women using combined oral contraceptives (COC) or progestogen-only contraceptives (POC) compared with women who had never used hormonal contraceptives. The potential influence of the duration of use was also investigated.
methodsA cross-sectional analysis was conducted in 120 healthy women aged 20–40 years, equally distributed into the COC, POC, and control groups. OCTA was used to measure foveal avascular zone (FAZ) parameters and vessel densities of the superficial and deep plexuses in a 3 × 3 mm scan. Macular and choroidal thickness were obtained using spectral-domain optical coherence tomography. One randomly selected eye of each participant was analyzed. Intergroup comparisons were performed using analysis of variance (ANOVA) or Kruskal–Wallis test, with appropriate post-hoc analyses; significance was set at 5%.
resultsNo significant differences were observed among the groups in FAZ parameters, macular thickness, or choroidal thickness. A small but statistically significant reduction in vessel density of the nasal parafoveal sector of the superficial capillary plexus was found in the POC subgroup with less than two years of use compared with controls (P = 0.033; post-hoc P = 0.049). No other significant differences were detected in the superficial or deep plexuses.
conclusionHormonal contraceptive use was not associated with significant alterations in FAZ parameters, macular or choroidal thickness, or overall retinal vessel density. A slight reduction in nasal parafoveal vessel density was observed in women with POC use for less than 2 years compared with controls, although the clinical significance of this finding remains uncertain. These results suggest that retinal vascular changes associated with hormonal contraceptives are minimal, underscoring the need for longitudinal studies with larger samples to confirm these observations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.